MIRA MIRA Pharmaceuticals Inc.: Net earnings per share for the last 12 months

MIRA Pharmaceuticals Inc. (MIRA) - corporate logo

Demand for neuropathic pain treatments remains stable and independent of macroeconomic conditions. MIRA Pharmaceuticals is currently developing synthetic analogs of ketamine and THC to combat depression without inducing hallucinations. Developing drugs across various niches mitigates overall risk. The EPS YoY TTM growth trajectory visualizes profit dynamics, where the -186.60 metric indicates the status of the current market phase.

MIRA Pharmaceuticals Inc. (MIRA) Net earnings per share (EPS TTM): for the period 11/23/2025 - 11/17/2026

MIRA Pharmaceuticals - analytical breakdowns and key metrics (MIRA)

Fundamental valuation:MIRA Pharma MIRA
Product sample of MIRA Pharma

This indicator measures the rolling year net earnings per share dynamics, allowing investors to assess business capitalization efficiency and the rate of change in profitability. Analyzing the annual EPS growth rate over the last 12 months helps identify a trend reversal in demand for MIRA Pharmaceuticals non-opioid analgesics prior to the publication of reports, confirming the successful commercialization of patented cannabinoids.

Competitor analysis

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Earnings per share for the last twelve months|India Globalization Capital - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Earnings per share for the last twelve months adialpharma.com (ADIL)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO